A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs

Overview

Journal Nanomaterials (Basel)

Date 2017 May 31

PMID 28554993

Citations 62

Authors

Qianwen Li

Tiange Cai

Yinghong Huang

Xi Xia

Susan P C Cole

Yu Cai

Affiliations

Soon will be listed here.

Abstract

Nanostructured lipid carriers (NLCs) are modified solid lipid nanoparticles (SLNs) that retain the characteristics of the SLN, improve drug stability and loading capacity, and prevent drug leakage. Polymer nanoparticles (PNPs) are an important component of drug delivery. These nanoparticles can effectively direct drug delivery to specific targets and improve drug stability and controlled drug release. Lipid-polymer nanoparticles (PLNs), a new type of carrier that combines liposomes and polymers, have been employed in recent years. These nanoparticles possess the complementary advantages of PNPs and liposomes. A PLN is composed of a core-shell structure; the polymer core provides a stable structure, and the phospholipid shell offers good biocompatibility. As such, the two components increase the drug encapsulation efficiency rate, facilitate surface modification, and prevent leakage of water-soluble drugs. Hence, we have reviewed the current state of development for the NLCs', PNPs', and PLNs' structures, preparation, and applications over the past five years, to provide the basis for further study on a controlled release drug delivery system.

Citing Articles

Hybrid Nanocomposite Mini-Tablet to Be Applied into the Post-Extraction Socket: Matching the Potentialities of Resveratrol-Loaded Lipid Nanoparticles and Hydroxyapatite to Promote Alveolar Wound Healing.

De Caro V, Tranchida G, La Mantia C, Megna B, Angellotti G, Di Prima G Pharmaceutics. 2025; 17(1).

PMID: 39861759 PMC: 11769172. DOI: 10.3390/pharmaceutics17010112.

Liposomal and Nanostructured Lipid Nanoformulations of a Pentacyclic Triterpenoid Birch Bark Extract: Structural Characterization and In Vitro Effects on Melanoma B16-F10 and Walker 256 Tumor Cells Apoptosis.

Rugina D, Socaciu M, Nistor M, Diaconeasa Z, Cenariu M, Tabaran F Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770472 PMC: 11728790. DOI: 10.3390/ph17121630.

Pimozide-loaded nanostructured lipid carriers: Repurposing strategy against lung cancer.

Al-Haj W, Nsairat H, El-Tanani M Sci Prog. 2024; 107(4):368504241296304.

PMID: 39497512 PMC: 11536680. DOI: 10.1177/00368504241296304.

Nanogene editing drug delivery systems in the treatment of liver fibrosis.

Wang Q, Jia S, Wang Z, Chen H, Jiang X, Li Y Front Med (Lausanne). 2024; 11:1418786.

PMID: 39386741 PMC: 11461213. DOI: 10.3389/fmed.2024.1418786.

PEGylation in Pharmaceutical Development: Current Status and Emerging Trends in Macromolecular and Immunotherapeutic Drugs.

Santhanakrishnan K, Koilpillai J, Narayanasamy D Cureus. 2024; 16(8):e66669.

PMID: 39262507 PMC: 11390148. DOI: 10.7759/cureus.66669.

References

Zhao X, Li F, Li Y, Wang H, Ren H, Chen J . Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Biomaterials. 2015; 46:13-25. DOI: 10.1016/j.biomaterials.2014.12.028. View

Luan J, Zhang D, Hao L, Qi L, Liu X, Guo H . Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Colloids Surf B Biointerfaces. 2013; 114:255-60. DOI: 10.1016/j.colsurfb.2013.10.018. View

Hussain A, Samad A, Singh S, Ahsan M, Faruk A, Jalees Ahmed F . Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B. Drug Dev Ind Pharm. 2014; 41(5):780-90. DOI: 10.3109/03639045.2014.902957. View

Vrignaud S, Benoit J, Saulnier P . Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011; 32(33):8593-604. DOI: 10.1016/j.biomaterials.2011.07.057. View

Rong X, Xie Y, Hao X, Chen T, Wang Y, Liu Y . Applications of polymeric nanocapsules in field of drug delivery systems. Curr Drug Discov Technol. 2011; 8(3):173-87. DOI: 10.2174/157016311796799008. View

Beloqui A, Solinis M, des Rieux A, Preat V, Rodriguez-Gascon A . Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs. Int J Pharm. 2014; 468(1-2):105-11. DOI: 10.1016/j.ijpharm.2014.04.027. View

Zhang K, Lv S, Li X, Feng Y, Li X, Liu L . Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin. Int J Nanomedicine. 2013; 8:3227-39. PMC: 3758216. DOI: 10.2147/IJN.S45031. View

Zhang W, Gao J, Zhu Q, Zhang M, Ding X, Wang X . Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm. 2010; 402(1-2):205-12. DOI: 10.1016/j.ijpharm.2010.09.037. View

Tolbert S, McFadden P, Loy D . New Hybrid Organic/Inorganic Polysilsesquioxane-Silica Particles as Sunscreens. ACS Appl Mater Interfaces. 2016; 8(5):3160-74. DOI: 10.1021/acsami.5b10472. View

10.

Peetla C, Stine A, Labhasetwar V . Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery. Mol Pharm. 2009; 6(5):1264-76. PMC: 2757518. DOI: 10.1021/mp9000662. View

11.

Kretlow J, Klouda L, Mikos A . Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007; 59(4-5):263-73. DOI: 10.1016/j.addr.2007.03.013. View

12.

Cai J, Huang H, Song W, Hu H, Chen J, Zhang L . Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro. Int J Pharm. 2015; 495(2):728-37. DOI: 10.1016/j.ijpharm.2015.09.055. View

13.

Hung L, Basri M, Tejo B, Ismail R, Nang H, Hassan H . An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Colloids Surf B Biointerfaces. 2011; 87(1):180-6. DOI: 10.1016/j.colsurfb.2011.05.019. View

14.

Abraham G, McCarroll J, Byrne F, Saricilar S, Kavallaris M, Bulmus V . Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery. J Biomater Sci Polym Ed. 2010; 22(8):1001-22. DOI: 10.1163/092050610X497872. View

15.

Gonullu U, Uner M, Yener G, Karaman E, Aydogmus Z . Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery. Acta Pharm. 2015; 65(1):1-13. DOI: 10.1515/acph-2015-0009. View

16.

Abdelwahab S, Sheikh B, Taha M, How C, Abdullah R, Yagoub U . Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration. Int J Nanomedicine. 2013; 8:2163-72. PMC: 3692342. DOI: 10.2147/IJN.S44108. View

17.

Zhang W, Gu X, Bai H, Yang R, Dong C, Liu J . Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug. Int J Pharm. 2010; 391(1-2):313-21. DOI: 10.1016/j.ijpharm.2010.03.011. View

18.

Uprit S, Sahu R, Roy A, Pare A . Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J. 2013; 21(4):379-85. PMC: 3824938. DOI: 10.1016/j.jsps.2012.11.005. View

19.

Pohlmann A, Fonseca F, Paese K, Detoni C, Coradini K, Beck R . Poly(ϵ-caprolactone) microcapsules and nanocapsules in drug delivery. Expert Opin Drug Deliv. 2013; 10(5):623-38. DOI: 10.1517/17425247.2013.769956. View

20.

Li J, He Y, Li W, Shen Y, Li Y, Wang Y . A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin. 2010; 31(4):509-14. PMC: 4007669. DOI: 10.1038/aps.2010.15. View